Physician profile
Sandra Gilley
NPI 1235342718
$8,268.99
in general payments reported to CMS, 2019-2025
46 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,569 · 2020: $999 · 2021: $1,283 · 2022: $2,038 · 2023: $2,224 · 2024: $51.37 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,379.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,575.55 | 2019-2023 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $1,219.10 | 2019-2023 | Fasenra, Tezspire, Breztri |
| Regeneron Healthcare Solutions, INC. | $964.82 | 2019-2023 | Dupixent |
| Grifols USA, LLC | $534.17 | 2019-2023 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $532.31 | 2019-2023 | Ofev |
| Mallinckrodt Hospital Products INC. | $429.12 | 2020-2023 | Acthar |
| Electromed, INC. | $327.44 | 2019-2023 | Smartvest |
| Genentech USA, INC. | $314.73 | 2019-2023 | Xolair |
| Inspire Medical Systems, INC. | $300.53 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $175.65 | 2019-2023 | Uptravi, Opsumit |
| Insmed, INC. | $164.78 | 2019-2020 | |
| Gilead Sciences, INC. | $153.60 | 2021-2024 | |
| Amgen INC. | $133.75 | 2022-2025 | Tezspire |
| Harmony Biosciences LLC | $112.57 | 2020-2023 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $107.67 | 2020-2023 | Glassia |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Gilley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.